Brief: Cartesian Therapeutics Reports Second Quarter 2025 Financial Results And Provides Business Update
07/08/2025 13:33
Aug 7 (Reuters) - Cartesian Therapeutics Inc RNAC.O: CARTESIAN THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE CARTESIAN THERAPEUTICS INC - Q2 NET INCOME $15.9 MILLION, EPS $0.51 Source text: ID:nGNX1fg2nw Further company coverage: RNAC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview